NCT02890069 2023-01-11A Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatNovartisPhase 1 Completed298 enrolled
NCT02071862 2022-07-20Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCalithera Biosciences, IncPhase 1 Completed210 enrolled